Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Tern PLC: Statement re: Device Authority Forecasts from September 2017

3 Aug 2018 07:00

Tern PLC (TERN) Tern PLC: Statement re: Device Authority Forecasts from September 2017 03-Aug-2018 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


August 2018

Tern Plc (AIM: TERN)

 

Statement re: Device Authority Forecasts from September 2017

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), seeks to clarify the RNS dated 29 September 2017, which included, inter alia, financial information for Device Authority Limited ("DA"), one of Tern's investee companies and in which Tern has a 56.8 per cent. holding.

 

The RNS of 29 September 2017 reproduced actual and forecast financial information regarding DA which DA's brokers, US Capital Partners, had made available on its website in order to promote a fundraising for DA. The forecasts were made public by Tern in order to ensure no disparity of information in the market. Both the RNS and the information on US Capital Partners website highlighted that the forecasts were conditional upon a full and successful $10m raise. The forecasts were prepared by the management of DA and the historic numbers were unaudited.

 

Tern announced on 1 February 2018 that the DA fundraise had not yet completed and was ongoing, signalling that further announcements would be made in respect of the fundraise. Tern announced its final results for the year ended 31 December 2017 on 27 March 2018, in which it was confirmed that DA did not achieve the announced revenue targets for 2017, and the DA fundraising had not yet been completed.

 

For the avoidance of any doubt, as the forecasts presented in the RNS of 29 September 2017 were conditional upon a successful and full completion of the proposed fundraise, Tern confirms that the DA forecasts of September 2017 are no longer relevant, and that DA does not have any forecast numbers in the public domain at the current time. The shareholders of DA remain supportive and have provided the company with $2,160,134 of additional funding by way of convertible loan notes since 30 November 2017, and further outside investment continues to be sought. Tern is pleased with the progress DA is making as outlined, for example, in the portfolio update announced on 16 May 2018 and subsequent announcements regarding the development of the strategic partnership with Thales.

 

An update on DA's performance will be provided in the Company's half yearly report for the six months ended 30 June 2018 which will be announced in the first half of September 2018.

 

 

Enquiries

 

Tern Plc

Al Sisto/Sarah Payne

Via Redleaf Communications

 

WH Ireland

(NOMAD and joint broker)

Mike Coe/Ed Allsopp

 

Tel: 0117 945 3470

 

Whitman Howard

(Joint broker)

Nick Lovering/Francis North

 

Tel: 020 7659 1234

 

Redleaf Communications

Elisabeth Cowell/Fiona Norman

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCU
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:5829
EQS News ID:710609
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th Dec 20247:01 amRNS-ROnline Investor Presentation and Q&A Session
16th Dec 20247:00 amRNSPlacing to raise £400,000
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSBoard Changes
25th Oct 20248:27 amRNSFurther re. Wyld Networks Rights Issue
15th Oct 20247:00 amRNSPlacing to raise £625,000
30th Sep 20245:04 pmRNSTotal Voting Rights
30th Sep 20247:00 amRNSDevice Authority Update
23rd Sep 202411:13 amRNSReplacement: Results of Open Offer
23rd Sep 202411:10 amRNSResult of General Meeting
23rd Sep 20247:00 amRNSResults of Open Offer
5th Sep 20247:00 amRNSOpen Offer and Notice of General Meeting
5th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
2nd Sep 202410:16 amRNSStatement re Wyld Networks Rights Issue
9th Aug 20247:00 amRNSPartial sale of Device Authority holding
27th Jun 202412:00 pmRNSResult of AGM
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResults for the year ended 31 December 2023
15th May 20247:00 amRNSExercise of Warrants
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.